Acetylcholine receptor antibodies as a marker of treatable fatigue in HIV-1 infected individuals.
Cupler
E J
EJ
Neuromuscular Diseases Section, National Institute of Neurologic Disorders and Stroke, NIH, Bethesda, Maryland 20892-1382, USA.
Otero
C
C
Hench
K
K
Luciano
C
C
Dalakas
M C
MC
D000328:Adult; D000906:Antibodies / Q000032:analysis*; D015415:Biomarkers; D005221:Fatigue / Q000150:complications / Q000188:drug therapy* / Q000276:immunology*; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D008297:Male; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000276:immunology*
D000906:Antibodies; D015415:Biomarkers; D011950:Receptors, Cholinergic; D011729:Pyridostigmine Bromide